ATE487692T1 - Verfahren und verbindungen zum nachweis von medizinischen erkrankungen - Google Patents

Verfahren und verbindungen zum nachweis von medizinischen erkrankungen

Info

Publication number
ATE487692T1
ATE487692T1 AT05758946T AT05758946T ATE487692T1 AT E487692 T1 ATE487692 T1 AT E487692T1 AT 05758946 T AT05758946 T AT 05758946T AT 05758946 T AT05758946 T AT 05758946T AT E487692 T1 ATE487692 T1 AT E487692T1
Authority
AT
Austria
Prior art keywords
compounds
methods
medical diseases
detecting medical
provides methods
Prior art date
Application number
AT05758946T
Other languages
English (en)
Inventor
Ilan Ziv
Anat Shirvan
Original Assignee
Aposense Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aposense Ltd filed Critical Aposense Ltd
Application granted granted Critical
Publication of ATE487692T1 publication Critical patent/ATE487692T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/49Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0404Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/01Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
    • C07C323/02Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/03Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05758946T 2004-07-08 2005-07-07 Verfahren und verbindungen zum nachweis von medizinischen erkrankungen ATE487692T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58585204P 2004-07-08 2004-07-08
PCT/IL2005/000725 WO2006006156A2 (en) 2004-07-08 2005-07-07 Compounds/methods for detection of medical disorders

Publications (1)

Publication Number Publication Date
ATE487692T1 true ATE487692T1 (de) 2010-11-15

Family

ID=35784250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05758946T ATE487692T1 (de) 2004-07-08 2005-07-07 Verfahren und verbindungen zum nachweis von medizinischen erkrankungen

Country Status (6)

Country Link
US (1) US8101666B2 (de)
EP (1) EP1773762B1 (de)
JP (1) JP2008505884A (de)
AT (1) ATE487692T1 (de)
DE (1) DE602005024690D1 (de)
WO (1) WO2006006156A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5322527B2 (ja) * 2008-07-17 2013-10-23 浜松ホトニクス株式会社 アポトーシスの検出に適した化合物
US11286246B2 (en) 2015-07-24 2022-03-29 Aposense Ltd. Pro-drugs and related methods
IL267919B2 (en) * 2017-01-09 2024-03-01 Aposense Ltd Compounds and methods for transmembrane transfer of molecules
IL275773B2 (en) 2018-01-01 2025-07-01 Aposense Ltd Compounds and methods for trans-membrane delivery of molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133303A1 (de) 1981-08-22 1983-03-03 Chemische Fabrik Pfersee Gmbh, 8900 Augsburg Verfahren zur herstellung von perfluoralkylreste enthaltenden kondensationsprodukten, die so hergestellten kondensationsprodukte und deren verwendung
US4677241A (en) * 1986-08-15 1987-06-30 Chevron Research Company Olefin oligomerization process and catalyst
US6322446B1 (en) * 1999-12-10 2001-11-27 Elot, Inc. System and a method for operating on-line state lottery games
US6586623B2 (en) * 2001-01-17 2003-07-01 Guilford Pharmaceuticals Inc. Thiol-based NAALADase inhibitors
EP1641742A4 (de) * 2003-05-01 2006-11-29 Nst Neurosurvival Technologies Verbindungen, die sich selektiv an membranen apoptotischer zellen binden
GB0327494D0 (en) * 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents

Also Published As

Publication number Publication date
WO2006006156A3 (en) 2006-12-07
US20070232702A1 (en) 2007-10-04
EP1773762B1 (de) 2010-11-10
JP2008505884A (ja) 2008-02-28
EP1773762A4 (de) 2008-12-10
WO2006006156A2 (en) 2006-01-19
US8101666B2 (en) 2012-01-24
DE602005024690D1 (de) 2010-12-23
EP1773762A2 (de) 2007-04-18

Similar Documents

Publication Publication Date Title
DE602005025106D1 (de) Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
ATE511645T1 (de) Testverfahren zum nachweis von antikörpern gegen lysosomenenzyme
GB2467467C (en) TAZ/WWTR1 for diagnosis and treatment of cancer
NO20092522L (no) Sammensetninger og fremgangsmater for a behandle kreft med cupredoxiner og CPG rikt DNA
WO2006085984A3 (en) Immune cell biosensors and methods of using same
ATE517638T1 (de) Verfahren und zubereitungen zum verabreichen von therapeutischen und diagnostischen mitteln
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
ATE457773T1 (de) Mittel zur funktionalen wiederherstellung eines geschädigten nervensystems
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
WO2006076025A3 (en) Immune cell biosensors and methods of using same
PL1838355T3 (pl) Ulepszone sposoby wygaszania dla procesu inaktywacji czerwonych krwinek
WO2006073682A3 (en) Diagnostic test
DE602005006990D1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
DK2076588T3 (da) Ekspansionsfremgangsmåde til voksne stamceller fra blod, især perifert blod, og dermed forbundet anvendelse på det medicinske område
CY1119653T1 (el) Μεθοδος για ταυτοποιηση της ευαισθησιας ενος ασθενους σε θεραπεια αναστολης της τελομερασης
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
WO2009022988A3 (en) Vhz for diagnosis and treatment of cancer
DE602006011607D1 (de) In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie
ATE487692T1 (de) Verfahren und verbindungen zum nachweis von medizinischen erkrankungen
ATE476661T1 (de) Krebsdiagnose und behandlung unter verwendung eines anti-robo1-antikörpers
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
WO2010036031A3 (en) Pauf-specific human monoclonal antibody, pharmaceutical composition for treating cancer comprising the same and method for detecting cancer using the same
WO2020023789A3 (en) Small rna predictors for alzheimer's disease
WO2006047475A3 (en) Detection and analysis of ophthalmically-relevant fluorescent molecules

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties